A Novel Molecular Grading Model: Combination of Ki67 and VEGF in Predicting Tumor Recurrence and Progression in Non-invasive Urothelial Bladder Cancer
Authors:
- Nan DengNDNan Deng
- Xu ChenXCXu Chen
- Ling-Wu ChenLCLing-Wu Chen
- Shao-Peng QiuSQShao-Peng Qiu
- Xiao-Fei LiXLXiao-Fei Li
- Jia-Ping LiJLJia-Ping Li
Open Access
- 30 May 2012
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 13 (5) , 2229-2234
Abstract
A Novel Molecular Grading Model: Combination of Ki67 and VEGF in Predicting Tumor Recurrence and Progression in Non-invasive Urothelial Bladder Cancer CKi67;VEGF;recurrence;progression;non-muscle invasive bladder cancer; Purpose: To assess efficacy of Ki67 combined with VEGF as a molecular grading model to predict outcomes with non-muscle invasive bladder cancer (NMIBC). Materials: 72 NMIBC patients who underwent transurethral resection (TUR) followed by routine intravesical instillations were retrospectively analyzed in this study. Univariate and multivariate analyses were performed to confirm the prognostic values of the Ki67 labeling index (LI) and VEGF scoring for tumor recurrence and progression. Results: The novel molecular grading model for NMIBC contained three molecular grades including mG1 (Ki67 $LI{\leq}25%$, VEGF $scoring{\leq}8$), mG2 (Ki67 LI>25%, VEGF $scoring{\leq}8$; or Ki67 $LI{\leq}25%$, VEGF scoring > 8), and mG3 (Ki67 LI > 25%, VEGF scoring > 8), which can indicate favorable, intermediate and poor prognosis, respectively. Conclusions: The described novel molecular grading model utilizing Ki67 LI and VEGF scoring is helpful to effectively and accurately predict outcomes and optimize personal therapy.
Keywords
This publication has 26 references indexed in Scilit:
- Biomarkers in bladder cancerBJU International, 2010
- Critical review of biomarkers for the early detection and surveillance of bladder cancerJournal of Men's Health, 2009
- Expression of VEGF in Urinary Bladder Transitional Cell Carcinoma in an Iraqi Population Subjected to Depleted UraniumApplied Immunohistochemistry & Molecular Morphology, 2009
- Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancerWorld Journal of Gastrointestinal Oncology, 2009
- Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladderPathology - Research and Practice, 2008
- Bladder Cancer: Management and Future DirectionsEuropean Urology Supplements, 2007
- The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladderBritish Journal of Cancer, 2006
- Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markersUrology, 2005
- Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomasAPMIS, 2003
- Predicting Cancer Progression in Patients With Stage T1 Bladder CarcinomaJournal of Clinical Oncology, 1999